Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.36 |
| ▸ | BRD4 | O60885 | 4/20 | 0.36 |
| ▸ | THRA | P10827 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5109654 | 0.90 | THRA (0.38) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL5118797 | 0.90 | SMN1; SMN2 (0.39) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL5104790 | 0.90 | BRD4 (0.36) | SMN1; SMN2BRD4THRATHRBALDH1A1 | |
| SCHEMBL5107711 | 0.90 | ALDH1A1 (0.39) | SMN1; SMN2BRD4ALDH1A1LMNAGAA | |
| SCHEMBL4931627 | 0.90 | SMN1; SMN2 (0.36) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL4932593 | 0.89 | THRA (0.35) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL4929941 | 0.88 | SMN1; SMN2 (0.38) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL5106726 | 0.86 | NR3C1 (0.34) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL4934028 | 0.86 | SMN1; SMN2 (0.36) | SMN1; SMN2THRATHRBALDH1A1LMNA | |
| SCHEMBL5103210 | 0.86 | HPGD (0.41) | SMN1; SMN2BRD4THRATHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080004251-A1 | Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor | KARO BIO AB (SE) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004251-A1 | Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor | TSHR, TRHR, THRA | SMN1; SMN2 4587/4885BRD4 1335/4885THRA 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.